A pharmaceutical factory which ceased production earlier this year has been bought by Britain's biggest defence firm. BAE ...

GlaxoSmithKline ( ($GB:GSK) ) has issued an announcement. GSK announced that the European Medicine Agency’s Committee for ...

GlaxoSmithKline (($GSK)) announced an update on their ongoing clinical study. Study Overview: GlaxoSmithKline (GSK) is conducting a Phase 3 ...

The FTSE 100 Index rose for four consecutive days and reached its all-time high of £9,578 as traders reacted to key earnings ...

A BAE Systems spokesperson said: “We can confirm BAE Systems has acquired the former GSK pharmaceutical manufacturing site in Ulverston, Cumbria. The site offers many redevelopment opportunities to ...

GSK's London-listed shares fell about 2% on Friday after the U.S. Food and Drug Administration approved only one of two ...

US regulators approved GSK Plc’s blood cancer drug, a decision that will allow the company to bring the medicine back to the ...

The approval is based on data from a Phase III trial evaluating patients who had received two or more previous treatments.

The new approval completes a surprise turnaround for Blenrep, which was initially cleared in 2020 but pulled from the market ...

Three years after its global market withdrawal and months after a negative advisory committee vote, GSK can officially call it a comeback for its multiple myeloma drug Blenrep in the U.S., albeit w | ...

The U.S. Food and Drug Administration has approved British drugmaker GSK's blood cancer drug, Blenrep, in one combination regimen, the company said on Thursday, clearing the way for its return to the ...